GSK (GSK) announces issued share capital and voting rights

Rhea-AI Filing Summary

GSK plc reports its issued share capital and total voting rights as of 31 August 2025. The company had 4,315,396,096 Ordinary Shares of 31 pence each, of which 244,408,471 were held in Treasury, leaving a total of 4,070,987,625 voting rights. Shareholders may use this figure as the denominator to determine whether they must notify changes in their holdings under the FCA Disclosure Guidance and Transparency Rules.

Positive

• Provides exact share and voting figures: 4,315,396,096 issued shares and 4,070,987,625 total voting rights.
• Compliance with disclosure rules: Meets FCA Disclosure Guidance and Transparency Rule 5.6.1R requirements and supplies a contact for notifications.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine regulatory disclosure of issued share capital and voting rights; useful for investor notification thresholds.

This Form 6-K provides the precise share count and Treasury share figure required under FCA rules, enabling shareholders to calculate disclosure thresholds accurately. The disclosure is administrative and does not convey operating or financial performance information. No other corporate actions, changes to share classes, or amendments to capital structure are reported in this filing.

Securities Compliance Analyst

TL;DR: Compliance-focused filing confirming total voting rights; no material change beyond routine reporting.

The filing fulfills Transparency Rule requirements by stating the total issued shares and Treasury holdings as of a specific date and provides a contact for notifications. This supports market transparency but contains no information that would typically be considered market-moving on its own.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

 GSK plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 August 2025 consisted of 4,315,396,096 shares of 31 ¼ pence each ('Ordinary Shares'), of which 244,408,471 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,070,987,625. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notifications may be sent to company.secretary@gsk.com.

V A Whyte

Company Secretary

1 September 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: September 01, 2025

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What are the total voting rights for GSK (GSK) as of 31 August 2025?

The filing states 4,070,987,625 total voting rights.

How many Ordinary Shares does GSK (GSK) have issued as of 31 August 2025?

GSK had 4,315,396,096 issued Ordinary Shares of 31 pence each.

How many of GSK's shares were held in Treasury on 31 August 2025?

The company held 244,408,471 Ordinary Shares in Treasury.

Why is the total voting rights figure important for shareholders of GSK (GSK)?

Shareholders use the total voting rights figure as the denominator to determine if they must notify changes in their interest under FCA Disclosure Guidance and Transparency Rules.

Who can shareholders contact with notifications regarding GSK (GSK)?

Notifications may be sent to company.secretary@gsk.com as provided in the filing.